Clinical Trials for Bladder Cancer

Sometimes numbers tell a story, but sometimes they obscure one. According to the latest figures from the National Cancer Institute, the death rate for people diagnosed with bladder cancer has hardly budged during the past 30 years. But experts who treat the disease tell a different and more hopeful tale—and they credit a surge in clinical trials for much of it. “In just the last fiv…

Read more

7 Myths About Cholesterol, Debunked

You may not recall every lab value from your last physical, but you probably remember one: Your cholesterol level.

If it’s higher than ideal, you’re not alone. According to the U.S. Centers for Disease Control and Prevention, between 2015 and 2018, almost 12% of U.S. adults ages 20 and up had high total cholesterol, defined as above 240 mg/dL. The type that physicians mostly w…

Read more

Inspiration4 and the Long History of Civilian Space Flight

TIME Studios is producing the Netflix documentary series Countdown: Inspiration 4 Mission to Space, starting Sept. 6.

It’s been 52 years since the artist Jeff Gates made a reservation to go to the Moon. Like many who gathered around their TV sets to watch the first lunar landing on July 20, 1969, Gates—then a 20-year-old college student home for summer vacation…

Read more

Ben Jealous’ Red State Plan for Sierra Club

In the world of climate advocacy groups, the Sierra Club is perhaps best known as a grassroots, progressive heavyweight. For years, it has fought to close coal plants, one by one, and more recently the group has called on the Biden administration to do more to address climate change.

So it may come as a surprise that Ben Jealous—the former NAACP head who was recently appointed as th…

Read more

Nobel Prize in Chemistry Awarded to First All-Female Team

Jennifer Doudna was sound asleep when her phone began buzzing, so she missed the first few calls. When the incessant ringing finally roused her at 3 a.m., it was a reporter who wanted her reaction to the just-awarded Nobel Prize in Chemistry.

“Who won?” Doudna asked.

“It was a little embarrassing,” Doudna said during a press conference held later in the day w…

Read more

Rethinking COVID Restrictions For a World With Vaccines

The arrival of Omicron, the latest and most transmissible COVID-19 variant to date, underscores the tremendous need for updated COVID-19 policy in the U.S. We always knew it would be difficult to contain a highly transmissible respiratory virus before Omicron. The arrival of the Delta variant forced us to abandon our goal of “herd immunity.” With the arrival of Omi…

Read more

Some Colleges Ignored Campus COVID-19 Models

Who thought it would be a good idea to move thousands of teenagers and young adults across the country to college campuses, where, unencumbered by parental supervision, many college kids did what college kids do?

Actually, Nigel Goldenfeld and Sergei Maslov, two University of Illinois at Urbana-Champaign physics researchers, thought they had it figured out. They created a predictive model…

Read more

Trump Wants to Send Astronauts Back to the Moon. Will That Really Happen-

The easiest part about going to the moon is, well, going to the moon. Once you’ve got your funding in place, your crew trained and your rocket and spacecraft on the launch pad, it’s just a matter of gassing it all up and going. We’ve done it before — nine times in fact; we can surely do it again.

The trick is all that other stuff that has to come first — espe…

Read more

U.S. Warned to Prepare for Costly Climate Change

The U.S. federal government should adopt a strategy to manage climate change risks, as their cost to the government may rise as much as $35 billion per year by mid-century, a congressional watchdog office report released on Monday said. The report from the non-partisan Government Accountability Office comes as Congress weighs aid packages for U.S. victims of deadly hurricanes and wildfires that…

Read more

What the CDC’s New COVID-19 Vaccine Recommendations Mean for You

In an Apr. 19 meeting, the vaccine committee of the U.S. Centers for Disease Control and Prevention (CDC) recommended that people ages 65 and older get a second bivalent mRNA booster. The panel also recommended additional boosters for people with weakened immune systems.

As a result of the new recommendations, the bivalent booster, which targets both the original and Omicron BA.4/5 viruse…

Read more